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Incidence, Predictive Factors and Impact of Delirium after Transcatheter
Aortic Valve Implantation
Masieh Abawi,1 Pieter R. Stella2
1UMC-Utrecht, Utrecht, Netherlands; 2University Medical Center
Utrecht, Utrecht, Netherlands
BACKGROUND To investigate the incidence, predictive factors and
impact of postoperative delirium (POD) among patients treated by
transcatheter aortic valve implantation.
METHODS A retrospective observational cohort study of 268 consec-
utive patients who underwent TAVI at our institute was conducted.
Delirium was diagnosed according to the Diagnostic and Statistical
Manual of Mental Disorder, 4rd Edition criteria. Primary outcome of
this study was the presence of inhospital POD after TAVI.
RESULTS The incidence of POD after TAVI was 13.4% (n¼36). Of these
cases, 18were associatedwith post-procedural complications, including
major vascular complications/bleeding (n¼4), stroke (n¼3), acute kid-
ney injury (n¼3), atrial ﬁbrillation (n¼4) and infectious disease (n¼4).
POD was most frequently diagnosed on the second day after TAVI (IQR:
1-5) and was associated with prolonged in-hospital stay regardless of
complications (inuncomplicatedTAVI: 6 [5-10] vs. 5 [4-5] days, P<0.001;
and in complicatedTAVI: 9 [8-15] vs. 6 [5-9] days, P<0.001). Predictors of
POD were non- transfemoral (transapical/transaortic) access (Odds
Radio (OR) 7.53; 95% conﬁdence interval [CI] 3.19-17.73), current
smoking (OR3.84; 95%CI 1.21 to 12.14), symptomatic carotid stenosis (OR
3.05; 95% CI 1.10 to 8.50), atrial ﬁbrillation (OR 2.61; 95% CI1.13 to 6.02)
and age (OR 1.09; 95% CI 1.00 to 1.18). After a median follow-up of
16 [6-27] months, patients who developed POD showed higher mortality
(36 % vs. 16%; P <0.001). POD remained a signiﬁcant independent
predictor of mortality when adjusted for age, sex and occurrence of
complications (Hazard Ratio (HR): 2.34; 95% CI 1.17 to 4.67).
CONCLUSIONS POD after TAVI has an incidence of 13% and occurs
early in the postoperative course. Non-transfemoral access is strongly
associated with the occurrence of POD. Patients who develop POD
show prolonged in-hospital stay and impaired long term survival.
CATEGORIES STRUCTURAL: Valvular Disease: Aortic
KEYWORDS Post-operative complication, Transcatheter aortic valve
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trans-catheter heart valves and its relation with aortic regurgitation
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BACKGROUND Patient- and procedure related factors are known to
be associated with aortic regurgitation (AR) after Transcatheter Aortic
valve Replacement (TAVR). Yet, AR may also be caused by a speciﬁc
device-host interaction. We sought to elucidate the role of frame ge-
ometry in the occurrence of aortic regurgitation after Medtronic Cor-
evalve (MCS) and Edward-SAPIEN valve (ESV) implantation.
METHODS One-hundred-and-ﬁfty consecutive patients who under-
went TAVR with the MCS or ESV in whom rotational angiography was
performed of whom 16 patients were excluded from analysis because
of poor image quality; total study population 134 (MCS 84, ESV 50).
Frame analysis was performed at 3 predeﬁned levels: MCS; inﬂow,
nadir of the leaﬂets and central coaptation, ESV; inﬂow, mid segment
and outﬂow. The degree of frame expansion was calculated by the
measured perimeter divided by nominal frame perimeter at the
inﬂow. The eccentricity at the nadir of the MCS frame and mid
segment of the ESV was adjusted to the eccentricity of the native
valve using the following equation: (Eccentricity nadir or midsegment – Eccentricity native annulus / Eccentricity native annulus) x
100. AR immediately post TAVI and at discharge was assessed using
contrast angiography (Sellers) and Doppler echocardiography
(VARC2). Distinction was made between patients with non and mild
and those with moderate and severe AR.
RESULTS Patients treated with the MCS valve underwent more often
balloon pre-dilation than patients treated with the ESV valve (95.2%
vs 82.0%, p¼0.012) and the size of the valve relative to aortic annulus
was larger in MCS treated patients for all MSCT-derived annulus. The
degree of expansion of the MCS valve was less at its inﬂow in com-
parison to the ESV (83  7 vs. 92  4, p < 0.001), but higher at its nadir
and coaptation. Yet, the MCS valve was more elliptical than the ESV at
all levels (Inﬂow: 82  8 vs. 95  3, p < 0.001; nadir/mid segment: 83 
8 vs. 95  4, p < 0.001; coaptation/outﬂow: 90  6 vs. 96  3, p <
0.001). This was also the case for the adjusted eccentricity (MCS 4  13
vs. ESV 21  11, p < 0.001) which was more prevalent in the MCS than
ESV treated (MCS 36% vs 2% p < 0.001). The rate of more-than-mild
AR was 23.6 % in the MCS vs. 13.6% in the ESV (p¼0.161). The absolute
and adjusted eccentricity at the nadir/mid segments and at the
coaptation/outﬂow were associated with signiﬁcant AR by echocar-
diography. This also holds for the presence of a frame more elliptical
than the native annulus (AR  moderate 48 vs. 17 %, p ¼ 0.002).
CONCLUSIONS Despite more oversizing, the inﬂow of the MCS frame
is less expanded than the ESV. Also, the MCS is more elliptical at all
the levels. Eccentricity was associated with more-than-mild AR. These
data indicate that intrinsic device related properties contribute to AR
post TAVI. “Disclaimer: The concepts and information presented in
this paper are based on research and are not commercially available.”
CATEGORIES STRUCTURAL: Valvular Disease: Aortic
KEYWORDS Rotational angiography, Transcatheter aortic valve re-
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BACKGROUND There is an increasing clinical experience with various
catheter-based valve technologies with different interaction with the
recipient. This has lead to an interest in on-line assessment of frame
geometry to better understand and/or to improve the immediate
result. The only technique that allows that assessment is rotational
angiography (R-angio). We sought to evaluate the determinants of
image quality of rotational angiography for on-line frame analysis
after Trans-catheter Aortic Valve replacement (TAVR).
METHODS A total of 179 patients underwent R-angio with motion
compensation after TAVR using 4 valves (Medtronic Corevalve (MCS,
n¼98), Edwars-SAPIEN (ESV, n¼52), Boston Sadra Lotus (BSL, n¼23),
St. Jude Medical Portico valve (SPV, n¼6). R-angio was performed
immediately acquiring 133 images in 5 seconds along a 198  arc during
breath hold. From the projection data a motion compensated 3D im-
age was reconstructed with research prototype software (Siemens AG,
Healthcare, Forchheim, Germany). Image quality was evaluated using
the following score: grade 1; excellent image quality, grade 2;
distinction between struts and artifacts possible, grade 3; some re-
gions distinction between struts and artifacts cannot be made, grade
4; degraded, grade 5; strongly degraded. Distinction was made be-
tween patients with good image quality (1, 2) and with insufﬁcient or
poor image quality (3-5). Multivariable logistic regression was used to
study the independent predictors of image quality
RESULTS Grade 1 & 2 image quality was achieved in 128 patients
(72%). By univariable analysis only valve type (BSL) and the presence
of an artefact (permanent pacemaker, TOE probe, pigtail, stitches,
prosthesis or other radiopaque objects) negatively affected image
quality. For valve type, the prevalence of good image quality - in
descending order of frequency – was; ESV (45/52, 86%), SPV (5/6,
83%), MCS (68/98, 69%) and BSL (10/23, 48%). Image quality was good
in 79% of the patients when no artefact was present vs 63% in the
presence of an artifact. Arrhythmia (e.g. atrial ﬁbrillation, premature
ventricular contractions) was present in 35/179 patients (20%) but did
not affect image quality (good image quality in 29/35, 83%). By
multivariate analysis (in which BMI was forced – BMI of patients with
good and poor image quality: 265 and 275, respectively), the
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in descending order of frequency: BSL valve (Odds 3.5 IC 95% [1.3 –
9.6], p¼0.02), presence of an artifact (Odds 2.5 IC 95% [1.2 – 5.4],
p¼0.02) and BMI (Odds 1.1 IC 95% [1.0 – 1.2], p¼0.04).
CONCLUSIONS R-angio with dedicated motion compensation soft-
ware offers good image quality for on-line frame analysis in 72% of the
patients. Image quality predominantly depends on valve type, pres-
ence of artefacts and patient-related variables such as BMI.
“Disclaimer: The concepts and information presented in this paper are
based on research and are not commercially available.”
CATEGORIES STRUCTURAL: Valvular Disease: Aortic
KEYWORDS Rotational angiography, Transcatheter aortic valve re-
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Extracranial Carotid And Vertebral Artery Disease And The Risk Of Stroke
Following Trans-catheter Aortic Valve Replacement
Chetan Huded,1 Quentin Youmans,1 Jyothy Puthumana,1 Ranya Sweis,1
Mark Ricciardi,1 S.C. Malaisrie,1 Charles J. Davidson,1 James Flaherty1
1Northwestern University, Chicago, IL
BACKGROUND Stroke is a feared complication of trans-catheter aortic
valve replacement (TAVR). Carotid and vertebral artery duplex ul-
trasonography is routinely obtained prior to TAVR, but the signiﬁ-
cance of extracranial carotid and vertebral artery disease (CVD) on the
risk of stroke following TAVR is unknown. The purpose of this study is
to assess the impact of CVD on the risk of stroke following TAVR.
METHODS We reviewed 294 consecutive cases of TAVR at a single
tertiary care academic medical center from June, 2008 to March, 2015.
We included 263 patients who underwent routine carotid and verte-
bral artery duplex ultrasonography prior to TAVR in a retrospective
cohort study. Patients with at least 50% stenosis of a carotid or
vertebral artery were identiﬁed as having CVD, and patients were
stratiﬁed into 2 groups by the presence or absence of CVD. The pri-
mary outcome was stroke within 30 days of TAVR. We adjudicated
stroke by the guideline recommendations of the Valve Academic
Research Consortium. Secondary outcomes included 30-day mortality
and overall survival following TAVR. We used chi2 and Fischer’s exact
tests to compare categorical variables and independent samples t tests
to compare continuous variables. We used Kaplan Meier life table
analysis to assess overall survival. We included univariate predictors
of stroke at P<0.10 in a multivariable logistic regression to identify
predictors of stroke after TAVR.
RESULTS CVD was present in 51 (19%) patients. The CVD group had
higher rates of coronary artery disease, prior coronary artery bypass
surgery, and peripheral artery disease compared to the non-CVD
group. There was no signiﬁcant difference in the rate of prior stroke or
the burden of aortic atheroma by intra-operative trans-esophageal
echocardiogram between CVD and non-CVD patients. Trans-femoral
access was less common in the CVD group (55% vs. 77%, p<0.01).
Stroke occurred in 18 (6.8%) patients within 30 days after TAVR. No
patients with CVD suffered a stroke. There was no difference in 30-
day mortality (10% vs 4%, p¼0.11) and overall survival (log-rank test,
p¼0.89) between the CVD and non-CVD groups. CVD was not a sig-
niﬁcant predictor of stroke following TAVR by logistic regression. In a
multivariable model, there were no signiﬁcant independent pre-
dictors of stroke after TAVR, but baseline antiplatelet therapy showed
a trend towards a protective effect, and higher pre-TAVR mean aortic
valve gradient showed a trend toward increased risk of stroke (table).Predictors of Stroke
Following TAVR Odds Ratio95% Conﬁdence
Interval PPrior coronary artery
bypass surgery0.33 0.04 to 1.89 0.32Prior dyslipidemia 0.40 0.11 to 1.38 0.15Baseline antiplatelet
therapy0.29 0.08 to 1.02 0.05Aortic atherosclerosis
> 2mm thickness3.71 0.68 to 20.12 0.13Trans-aortic access 3.41 0.56 to 20.97 0.19Pre-TAVR mean aortic
valve gradient
(increasing
continuous variable
by mm Hg)1.05 1.00 to 1.11 0.07CONCLUSIONS CVD is not associated with an increased risk of stroke
or death following TAVR. The routine screening of CVD prior to TAVR
does not appear justiﬁed.
CATEGORIES STRUCTURAL: Valvular Disease: Aortic
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BACKGROUND Patients with severe aortic stenosis who are referred
for transcatheter aortic valve replacement (TAVR) need to meet aortic
root and aortic annular anatomical inclusion criteria. We sought to
characterize the number of patients that could not have the currently
available transcatheter valves (Sapien XT and CoreValve).
METHODS We screened 400 patients with severe aortic stenosis who
were referred for TAVR between 2010-2014 who had had multi-de-
tector computed tomographic (MDCT) imaging. Annulus measure-
ments of the basal ring (short- and long-axis, area-derived diameter),
coronary ostia height, sinus area (SA), sino-tubular junction area
(STJ), calciﬁcation and eccentricity index (EI, 1-short axis/long axis)
were made.
RESULTS The vast majority of patients were able to be offered a
currently available TAVR valve (88%). We identiﬁed 49 patients who
were excluded for anatomical annular characteristics alone. Large
aortic annuli were the most common reason for anatomical exclusion
[704  79 mm2; (n¼ 39, 80 %)]. In addition these large annuli were
more elliptical (EI, 1.39  0.1) with more eccentric calciﬁcation (68 %).
The presence of low coronary heights (n¼6 mm: n¼19, 18 %) from the
aortic annular plane was the next most common reason. The left main
coronary artery was more commonly lower than the right coronary
artery and low coronary heights with effaced coronary sinuses
appeared occur together (n¼11, 57 %). Small aortic annuli were the
least common [290  50 mm2; n¼1, 2 %) cause for exclusion from
TAVR therapy. None of the patients who were excluded form TAVR
therapy had more than one annular reason for TAVR exclusion.
CONCLUSIONS Most patients with severe aortic stenosis who are
referred for TAVR can be offered a transcatheter valve. However, 12 %
of patients cannot be offered a therapy due to annular anatomical
exclusion criteria. This was primarily due to the presence of large
aortic annuli and low coronary heights.
CATEGORIES STRUCTURAL: Valvular Disease: Aortic
KEYWORDS Aortic stenosis, TAVR
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BACKGROUND The repositionable, fully retrievable, CE-marked
Lotus Valve is designed to facilitate controlled, precise positioning
and minimize paravalvular aortic regurgitation. Results to 3 years
post-implantation with Lotus have not yet been reported.
METHODS REPRISE I is a prospective, single-arm, 3-center feasibility
study designed to assess acute safety and performance of the 23mm
Lotus Valve in symptomatic patients with calciﬁed aortic stenosis who
were considered high surgical risk by the Heart Team.
RESULTS The Lotus Valve was implanted in 11 female patients with a
mean age 83.03.6 years and a mean STS score 4.92.5%). Frailty
measures included gait speed 6s (9/11), grip strength 18kg
(7/11), and cognitive dysfunction (5/11; deﬁned as a score <4 on the
